1. Home
  2. UPLD vs RVPH Comparison

UPLD vs RVPH Comparison

Compare UPLD & RVPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Upland Software Inc.

UPLD

Upland Software Inc.

HOLD

Current Price

$0.71

Market Cap

28.4M

Sector

Technology

ML Signal

HOLD

Logo Reviva Pharmaceuticals Holdings Inc.

RVPH

Reviva Pharmaceuticals Holdings Inc.

HOLD

Current Price

$0.87

Market Cap

29.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UPLD
RVPH
Founded
2010
2006
Country
United States
United States
Employees
N/A
14
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
28.4M
29.2M
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
UPLD
RVPH
Price
$0.71
$0.87
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
7
Target Price
$3.75
$66.67
AVG Volume (30 Days)
374.8K
2.6M
Earning Date
03-03-2026
03-30-2026
Dividend Yield
N/A
N/A
EPS Growth
63.38
N/A
EPS
N/A
N/A
Revenue
$74,767,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$1.95
N/A
P/E Ratio
N/A
N/A
Revenue Growth
6.95
N/A
52 Week Low
$0.50
$0.17
52 Week High
$3.90
$3.11

Technical Indicators

Market Signals
Indicator
UPLD
RVPH
Relative Strength Index (RSI) 44.52 45.43
Support Level $0.51 $0.32
Resistance Level $1.62 N/A
Average True Range (ATR) 0.07 0.24
MACD 0.02 -0.13
Stochastic Oscillator 68.98 23.90

Price Performance

Historical Comparison
UPLD
RVPH

About UPLD Upland Software Inc.

Upland Software Inc is a software company. It provides cloud-based software applications in three categories: Knowledge Management that provides solutions designed to help organizations capture, organize, and distribute information to employees and customers. Content Lifecycle and Workflow Automation offers solutions that support document management, compliance, and process efficiency across various industries. Digital Marketing solutions that provides tools for audience engagement, campaign management, and content distribution across digital channels.

About RVPH Reviva Pharmaceuticals Holdings Inc.

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.

Share on Social Networks: